Early Morning Insight: United Therapeutics, Pharmacyclics, Star Scientific, and Impax Laboratories

 Early Morning Insight: United Therapeutics, Pharmacyclics, Star Scientific,                             and Impax Laboratories  Editor Note: For more information about this release, please scroll to bottom.  PR Newswire  LONDON, July 29, 2013  LONDON, July 29, 2013 /PRNewswire/ --  On Friday, July 26, 2013, shares of drug manufacturers ended mostly lower even as the broader market posted small gains. The major movers in the sector included United Therapeutics Corporation (NASDAQ: UTHR), Pharmacyclics, Inc. (NASDAQ: PCYC), Star Scientific, Inc. (NASDAQ: STSI), and Impax Laboratories Inc. (NASDAQ: IPXL). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on UTHR, PCYC, STSI, and IPXL now at:  http://www.aaaresearchreports.com/register/  Shares of United Therapeutics Corporation moved higher on Friday, extending their gains for the week. The company's shares oscillated between $71.12 and $72.67 before finishing the day 0.93% higher at $72.50. A total of 340,254 shares were traded, which is below the daily average volume of 585,466. United Therapeutics' shares gained 3.57% last week as compared to a loss of 0.03% in the S&P 500. Further, the stock is currently trading near its 52-week high of $74.46. Download free research on UTHR today by registering at:  http://www.AAAResearchReports.com/UTHR072913.pdf  Pharmacyclics, Inc.'s stock edged lower on Friday, extending its loss for the week. The company's shares oscillated between $101.81 and $103.92 before closing the day 0.25% lower at $103.45. A total of 337,206 shares were traded, which is below the daily average volume of 961,229. Pharmacyclics' shares fell by 4.33% last week, underperforming the S&P 500. Nonetheless, the stock has advanced 30.17% in the last one month, outperforming the S&P 500, which has gained 5.31% in the same period. Sign up and have access to our free report on PCYC at:  http://www.AAAResearchReports.com/PCYC072913.pdf  Shares of Star Scientific, Inc. slipped on Friday even as the broader market posted gains. The company's shares oscillated between $1.92 and $1.98 before ending the session 0.51% lower at $1.94. A total of 546,340 shares were traded, which is below the daily average volume of 1.16 million. The stock has fallen 3.00% in the last three trading sessions. However, it has gained 39.57% in the last one month, outperforming the S&P 500. Sign up and read the complimentary report on STSI at:  http://www.AAAResearchReports.com/STSI072913.pdf  Impax Laboratories Inc.'s stock moved lower on Friday, reversing some of its gains for the week. The company's shares oscillated between $20.63 and $20.99 before finishing the day 0.14% lower at $20.94. A total of 214,306 shares were traded, which is below the daily average volume of 731,357. The stock gained 1.60% last week, 5.03% in the last one month and 18.84% in the last three months. The free report on IPXL can be downloaded by signing up now at:  http://www.AAAResearchReports.com/IPXL072913.pdf  EDITOR NOTES:  1.This is not company news. We are an independent source and our views do     not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts     basis and reviewed by a CFA. However, we are only human and are prone to     make mistakes. If you notice any errors or omissions, please notify us     below. 3.This information is submitted as a net-positive to companies mentioned, to     increase awareness for mentioned companies to our subscriber base and the     investing public. 4.If you wish to have your company covered in more detail by our team, or     wish to learn more about our services, please contact us at     pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquires, please contact us at     compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your     company? Send us a full investors' package to     research@EquityNewsNetwork.com for consideration.  COMPLIANCE PROCEDURE  Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.  NOT FINANCIAL ADVICE  Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.  NO WARRANTY OR LIABILITY ASSUMED  Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.  SOURCE AAA Research Reports  Contact: AAAresearchreports.com Phone #: + 1(646)396-9126  
Press spacebar to pause and continue. Press esc to stop.